Evoke Pharma, Inc. (NASDAQ:EVOK ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Quesenberry – Chief Commercial Offic
SOLANA BEACH, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced

Biotech Penny Stocks Investing Guide

04:47pm, Monday, 20'th Jun 2022
What to know about trading biotech stocks in 2022 The post Biotech Penny Stocks Investing Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why These 3 Penny Stocks Exploded Today

03:38pm, Wednesday, 15'th Jun 2022
Why these three penny stocks exploded during trading today The post Why These 3 Penny Stocks Exploded Today  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Evoke Pharma (EVOK) stock is rocketing higher on Wednesday after the company got Medicaid approval for its GIMOTI nasal spray. The post Evoke Pharma (EVOK) Stock Soars 50% on Medicaid Drug Approval ap
A 1-for-12 reverse stock split of Evoke Pharma (NASDAQ: EVOK) has gone into effect. These are the details.
Penny stocks to watch under $1 today. The post Penny Stocks To Buy Now?
Penny stocks to watch under $1 today. The post Penny Stocks To Buy Now?
Evoke Pharma, Inc. EVOK Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Quesenberry – Chief Commercial Officer, EVERSANA
Top penny stocks under $1 to watch in May. The post 10 Top Penny Stocks To Buy For Under $1 May 2022 Edition appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why these 3 penny stocks are climbing today The post 3 Hot Penny Stocks to Watch as EVOK Stock Climbs 120% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Is Evoke Pharma (EVOK) Stock Up 130% Today?

02:17pm, Tuesday, 26'th Apr 2022
Evoke Pharma is up an unbelievable 130% today on news of recently granted drug exclusivity. How high will EVOK stock soar?
Evoke Pharma press release (EVOK): Q4 GAAP EPS of $0.05 beats by $0.13.Revenue of $0.36M (+1700.0% Y/Y) misses by $0.15M.
Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE